with first data readout expected in summer 2025 European Committee for Medicinal Products for Human Use (CHMP) review of ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November ...

Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by 7% quarter-over-quarter, with U.S. net product revenue ...

KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake.

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

State lawmakers are considering a bill that would legalize production and use of psilocybin as a mental health treatment in ...

Kate Kendall’s script landed at the same time as Sydney’s first Covid lockdowns. A successful fitness entrepreneur and yoga ...

According to the WHO, about 40 percent of pharmaceutical products are based on natural sources, and 70 percent of people ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...